BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 19682919)

  • 1. Growth suppressive cytokines and the AKT/mTOR pathway.
    Kroczynska B; Kaur S; Platanias LC
    Cytokine; 2009; 48(1-2):138-43. PubMed ID: 19682919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statin-dependent suppression of the Akt/mammalian target of rapamycin signaling cascade and programmed cell death 4 up-regulation in renal cell carcinoma.
    Woodard J; Sassano A; Hay N; Platanias LC
    Clin Cancer Res; 2008 Jul; 14(14):4640-9. PubMed ID: 18628479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IGF-1-stimulated protein synthesis in oligodendrocyte progenitors requires PI3K/mTOR/Akt and MEK/ERK pathways.
    Bibollet-Bahena O; Almazan G
    J Neurochem; 2009 Jun; 109(5):1440-51. PubMed ID: 19453943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of mRNA translation of interferon stimulated genes.
    Joshi S; Kaur S; Kroczynska B; Platanias LC
    Cytokine; 2010; 52(1-2):123-7. PubMed ID: 20409730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expanding mTOR signaling.
    Yang Q; Guan KL
    Cell Res; 2007 Aug; 17(8):666-81. PubMed ID: 17680028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mammalian target of rapamycin-signaling pathway in regulating metabolism and growth.
    Yang X; Yang C; Farberman A; Rideout TC; de Lange CF; France J; Fan MZ
    J Anim Sci; 2008 Apr; 86(14 Suppl):E36-50. PubMed ID: 17998426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Critical and diverse involvement of Akt/mammalian target of rapamycin signaling in human lung carcinomas.
    Dobashi Y; Suzuki S; Matsubara H; Kimura M; Endo S; Ooi A
    Cancer; 2009 Jan; 115(1):107-18. PubMed ID: 19090006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KAI1/CD82 decreases Rac1 expression and cell proliferation through PI3K/Akt/mTOR pathway in H1299 lung carcinoma cells.
    Choi UJ; Jee BK; Lim Y; Lee KH
    Cell Biochem Funct; 2009 Jan; 27(1):40-7. PubMed ID: 19107873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. mTOR, translation initiation and cancer.
    Mamane Y; Petroulakis E; LeBacquer O; Sonenberg N
    Oncogene; 2006 Oct; 25(48):6416-22. PubMed ID: 17041626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. mTOR signaling and the molecular adaptation to resistance exercise.
    Bodine SC
    Med Sci Sports Exerc; 2006 Nov; 38(11):1950-7. PubMed ID: 17095929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin inhibition of apolipoprotein B mRNA translation is mediated via the PI-3 kinase/mTOR signaling cascade but does not involve internal ribosomal entry site (IRES) initiation.
    Sidiropoulos KG; Meshkani R; Avramoglu-Kohen R; Adeli K
    Arch Biochem Biophys; 2007 Sep; 465(2):380-8. PubMed ID: 17698027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of mTOR in the management of solid tumors: an overview.
    Strimpakos AS; Karapanagiotou EM; Saif MW; Syrigos KN
    Cancer Treat Rev; 2009 Apr; 35(2):148-59. PubMed ID: 19013721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting AKT signaling sensitizes cancer to cellular immunotherapy.
    Hähnel PS; Thaler S; Antunes E; Huber C; Theobald M; Schuler M
    Cancer Res; 2008 May; 68(10):3899-906. PubMed ID: 18483275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the AKT/mTOR pathway in autosomal recessive polycystic kidney disease (ARPKD).
    Fischer DC; Jacoby U; Pape L; Ward CJ; Kuwertz-Broeking E; Renken C; Nizze H; Querfeld U; Rudolph B; Mueller-Wiefel DE; Bergmann C; Haffner D
    Nephrol Dial Transplant; 2009 Jun; 24(6):1819-27. PubMed ID: 19176689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The PI3' kinase pathway in interferon signaling.
    Kaur S; Uddin S; Platanias LC
    J Interferon Cytokine Res; 2005 Dec; 25(12):780-7. PubMed ID: 16375606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Akt and mRNA translation by interferons.
    Kaur S; Katsoulidis E; Platanias LC
    Cell Cycle; 2008 Jul; 7(14):2112-6. PubMed ID: 18635959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of the effect of amino acids on an integrated mTOR and insulin signaling pathway.
    Vinod PK; Venkatesh KV
    Mol Biosyst; 2009 Oct; 5(10):1163-73. PubMed ID: 19756306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The PI3K/Akt/mTOR pathway in innate immune cells: emerging therapeutic applications.
    Weichhart T; Säemann MD
    Ann Rheum Dis; 2008 Dec; 67 Suppl 3():iii70-4. PubMed ID: 19022819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A hierarchical cascade activated by non-canonical Notch signaling and the mTOR-Rictor complex regulates neglect-induced death in mammalian cells.
    Perumalsamy LR; Nagala M; Banerjee P; Sarin A
    Cell Death Differ; 2009 Jun; 16(6):879-89. PubMed ID: 19265851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Akt regulates skeletal development through GSK3, mTOR, and FoxOs.
    Rokutanda S; Fujita T; Kanatani N; Yoshida CA; Komori H; Liu W; Mizuno A; Komori T
    Dev Biol; 2009 Apr; 328(1):78-93. PubMed ID: 19389373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.